Hematologic Malignancies Market Size to Reach USD 147.71 Billion by 2033 | Straits Research
According to Straits Research, the global hematologic malignancies market was valued at USD 72.87 billion in 2024 and is projected to grow significantly, reaching USD 147.71 billion by 2033. The market is expected to expand at a compound annual growth rate (CAGR) of 8.14% during the forecast period (2025–2033). This growth underscores the rising demand for advanced diagnostic and therapeutic solutions in the field of hematologic cancers, including leukemia, lymphoma, and multiple myeloma.
Download Free Sample Report with Complimentary Analyst Consultation : https://straitsresearch.com/re....port/hematologic-mal
Like
Comment
Share
